flow semaglutide trial FLOW- the Visual Abstract — NephJC flow trial semaglutide kidney outcomes

Most people give it as a subcutaneous injection, meaning just under the skin, not into muscle

GLP-1 therapy removes that interference

Your doctor will typically start with a low dosage of Ozempic and adjust it over time to reach an amount thats right for you

Nothing worth being proud of comes [easily], and this is no exception

Clavero-Jimeno, A

For example, after a median observation time of 2.1 years in the SUSTAIN 6 clinical trial, once-weekly semaglutide was shown to significantly reduce the rate of nonfatal myocardial infarction, nonfatal stroke and cardiovascular death in patients with T2D who were at high cardiovascular risk [9]